An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma

Local Institution - 0055, New York

Broome Oncology, Johnson City

Local Institution - 0053, Buffalo

Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore

Local Institution - 0047, Richmond

Local Institution - 0032, Norfolk

Local Institution - 0017, Roanoke

Local Institution - 0020, Charleston

Baptist Health Medical Group Oncology, Miami

Local Institution - 0007, St. Petersburg

Local Institution - 0008, Fort Myers

Local Institution - 0004, Nashville

Local Institution - 0005, Chattanooga

Local Institution - 0012, Germantown

Norton Cancer Institute, Louisville

Local Institution - 0052, Fort Wayne

Illinois Cancer Specialists, Niles

HCA Midwest Division, Kansas City

Local Institution - 0011, Omaha

Urology Cancer Center Laboratory, Omaha

Southeast Nebraska Hematology & Oncology Consultants, P.C., Lincoln

Local Institution - 0001, Tulsa

Local Institution - 0015, Dallas

The Center For Cancer And Blood Disorders, Fort Worth

Local Institution - 0034, Houston

Local Institution - 0021, San Antonio

University Of Colorado, Aurora

Local Institution - 0018, Lakewood

Local Institution - 0028, Grand Junction

Local Institution - 0030, Phoenix

Local Institution - 0014, Las Vegas

Cancer Care Associates Medical Group, Inc., Redondo Beach

St. Jude Hospital Yorba Linda, Fullerton

Sansum Santa Barbara Medical Foundation Clinic, Santa Barbara

Comprehensive Blood And Cancer Center, Bakersfield

Local Institution - 0039, Seattle

Local Institution - 0054, Tampa

Local Institution - 0016, Portland

Texas Cancer Center - Sherman, Sherman